Lycopene Concentration Measurement for Tissue Discrimination

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current apparatuses for optical analysis of tissues, particularly in the prostate organ, are not sufficient for discriminating between normal and diseased tissue types, especially in early-stage prostate cancer, as they fail to accurately determine the concentration of lycopene, a key differentiating feature.

Innovation Solution

An apparatus utilizing Diffuse Reflectance Spectroscopy (DRS) with a spectrometer and interventional device to measure the concentration of lycopene in tissues, enabling the differentiation between normal and tumor tissues by analyzing the optical spectrum and determining a parameter indicative of tissue type.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional optical analysis methods are used to detect tissue differences, then blood content discrimination is possible, but the ability to discriminate tissue types in early stage prostate cancer is insufficient

Engineering Contradiction:
Improvetissue type discrimination accuracyVSAvoidearly stage cancer detection reliability
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The invention changes the measurement parameter from general optical properties to specific lycopene concentration measurement. By targeting the specific spectral absorption characteristics of lycopene at 468-472 nm, the system achieves precise discrimination of tissue types based on lycopene concentration differences between normal and cancerous tissues, resolving the insufficiency of conventional methods.

Inventive Principle:
Principle #35Parameter changes

2Loss of information

If Raman spectroscopy is used to detect tissue samples, then spectral information can be obtained, but the device complexity increases with multiple optical fibers and separation modules

Engineering Contradiction:
Improvespectral information completenessVSAvoidoptical module complexity
Core Design Contradiction:
Loss of informationVSDevice complexity

Solution Approach 1:

The invention extracts only the essential information needed for tissue discrimination - the lycopene concentration - by measuring absorption at a specific wavelength range (468-472 nm). This eliminates the need for complex Raman spectroscopy systems with multiple optical fibers, beam splitters, and spectral separation modules, while still providing sufficient discriminatory information.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

Instead of analyzing the entire spectrum, the invention focuses measurement on a specific local region - the lycopene absorption peak at 468-472 nm. This localized measurement approach provides the necessary tissue discrimination capability while significantly simplifying the optical system compared to full-spectrum Raman analysis.

Inventive Principle:
Principle #3Local quality

3Measurement precision

If multiple chromophores are present in tissue, then comprehensive tissue characterization is possible, but the specific concentration determination of individual chromophores becomes difficult

Engineering Contradiction:
Improvelycopene concentration precisionVSAvoidchromophore mixture complexity
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The invention changes the measurement approach from attempting to quantify all chromophores simultaneously to specifically targeting lycopene concentration by measuring absorption at its characteristic wavelength (468-472 nm). This selective parameter measurement enables precise lycopene determination even in the presence of multiple other chromophores in the tissue.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables precise and reliable discrimination between normal and tumor tissues by accurately measuring lycopene concentration, facilitating accurate treatment targeting and improving diagnostic accuracy in surgical oncology.

Implementation Method 1

a light source (104) and a detector (106, 108) arranged to measure an optical spectrum

Methodology Applied
Scientific EffectLight emission: Light

Implementation Method 2

measuring an optical spectrum... determination of a first parameter being indicative of a concentration of lycopene... optical absorption characteristics

Methodology Applied
Scientific EffectOptical absorption: Absorption (EM radiation)

Data Source

PatentEP2806785B1An apparatus for optical analysis of an associated tissue
Publication Date: 2016.09.21 KONINKLIJKE PHILIPS NV
  • EP2806785B1 patent drawingFigure 1~2
  • EP2806785B1 patent drawingFigure 3
  • EP2806785B1 patent drawingFigure 4

AI summary

The present invention relates to an apparatus 100 and, a method and a computer program for determining a first parameter indicative of a concentration of lycopene. In particular, the invention relates to an apparatus 100 comprising a spectrometer 02, which spectrometer comprises a light source 104 and a detector 106, 108 arranged to measure an optical spectrum via an interventional device 112. This enables determination of a first parameter being indicative of a lycopene concentration. Lycopene concentration may serve as a discriminative feature for different tissue types, such as the prostate organ and associated structures. The apparatus may in a specific embodiment be arranged to determine a second parameter indicative of a tissue type based on a concentration of lycopene. According to a specific embodiment, the apparatus relies on Diffuse Reflectance Spectroscopy (DRS).